Title : Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.

Pub. Date : 2021 Feb 15

PMID : 32720318






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer. taxane BRCA1 DNA repair associated Homo sapiens
2 In this retrospective study, we aimed to explore the efficacy of anthracycline-taxane- or anthracycline-taxane/carboplatin-based neoadjuvant chemotherapy in BRCA1/2-mutated triple-negative breast cancer. taxane BRCA1 DNA repair associated Homo sapiens
3 In this retrospective study, we aimed to explore the efficacy of anthracycline-taxane- or anthracycline-taxane/carboplatin-based neoadjuvant chemotherapy in BRCA1/2-mutated triple-negative breast cancer. taxane BRCA1 DNA repair associated Homo sapiens
4 Our study suggested that BRCA1/2-mutated triple-negative breast cancer patients gain a survival benefit when carboplatin is added to standard anthracycline-taxane-based neoadjuvant chemotherapy. taxane BRCA1 DNA repair associated Homo sapiens